April 2018 - GoforIsrael

Eloxx Pharmaceuticals Announces FDA Grant of Orphan-Drug Designation for Investigational Drug ELX-02 for Treatment of Cystinosis

by GoforIsrael | Apr 30, 2018 | Articles, Newsroom

Israeli Policymakers Divided Over Response to U.S. Tax Policy

by GoforIsrael | Apr 30, 2018 | Articles, Newsroom

In the past five years, Chinese investors have accounted for some $15 billion of the approximately $25 billion invested in Israeli technology, said Edouard Cukierman, chairman of Cukierman & Co. Investment House Ltd. and managing partner of Catalyst Investments...

Israeli Semiconductor Industry (Chinese)

by GoforIsrael | Apr 30, 2018 | Articles, Newsroom

Eloxx Pharmaceuticals Announces FDA Grant of Orphan-Drug Designation for Investigational Drug ELX-02 for Treatment of Cystinosis

Israeli Policymakers Divided Over Response to U.S. Tax Policy

Israeli Semiconductor Industry (Chinese)

Recent Posts

Recent Comments

Archives

Categories

The Conference addresses current issues in fundraising and establishes strategic alliances globally between Israeli companies, businesses and financial institutions.

For more information to apply as a Speaker or a Sponsor for our next conference please contact:

Aron Pacifici